by David Brennan | Sep 11, 2025 | News
Aurum Biosciences has been invited to speak at a flagship life sciences conference in the US, further fostering its growth ambitions Aurum Biosciences which is a spinout of NHS Greater Glasgow and Clyde, InnoScot Health, and the University of Glasgow, is a...
by David Brennan | Mar 19, 2024 | News
Scottish biopharmaceutical company Aurum Biosciences has been invited to speak at a flagship life sciences conference in London this April, allowing it to demonstrate the huge potential of its technology to advance the management of acute stroke patients A spinout of...
by David Brennan | Jan 24, 2024 | News
Scottish biopharmaceutical company Aurum Biosciences has raised almost £730,000 in the first tranche of a new round of equity funding aimed at further developing its state-of-the-art therapeutic and diagnostic technology and setting up fresh success in 2024.The...
by David Brennan | Feb 28, 2023 | News
Aurum Biosciences, a clinical stage biopharmaceutical company based in Scotland has been awarded an Innovation Passport for its breakthrough stroke technology A 2015 spinout company of InnoScot Health, NHS Greater Glasgow and Clyde, and the University of Glasgow,...
by David Brennan | Feb 7, 2023 | News
Glasgow-based novel biopharmaceuticals company Aurum Biosciences has appointed a new CEO as it looks to further expand its global presence A 2015 clinical stage spinout company of InnoScot Health, NHS Greater Glasgow and Clyde, and the University of Glasgow, Aurum...
